Peptide Decoding
New?New to peptides?Start here →All blends →
Decoding

Coremend blend (TB-500 / BPC-157 / KPV)_Dosage, benefits & legal status

Also known as Coremend, TB-500 + BPC-157 + KPV, BPC-157 + TB-500 + KPV, KPV + BPC-157 + TB-500, Tri Blend, Tri-Heal, BPC/TB/KPV

Published August 24, 2026 · Updated September 19, 2026

A named healing triple that is the Wolverine blend with KPV added.

Healing & recoveryTB-500 + BPC-157 + KPV blendResearch only
Dose0.25 up to 0.5 mg BPC-157 per day (the rest follows your ratio)
FrequencyVaries
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNot established for the blend

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Coremend blend (TB-500 / BPC-157 / KPV)?

Plain language first. The technical label stays, but it never stands alone.

Overview

The Wolverine blend with KPV added. The TB-500 share is two and a half times the others, so a dose worked out for a 1:1 vial gives you far more TB-500 than you expect.

The technical version

A research-market three-peptide co-formulation supplied as TB-500 25 mg, BPC-157 10 mg and KPV 10 mg in a 45 mg vial, sold under the product name Coremend. Compositionally it is the BPC-157 plus TB-500 pairing with the alpha-MSH fragment KPV added, and it differs from the KLOW blend by the absence of GHK-Cu. No published trial has evaluated the combination.

What it's used for

An injected three-peptide blend sold for tissue repair, recovery and inflammation.

02

How does Coremend blend (TB-500 / BPC-157 / KPV) work?

What it does in the body, and where.

Coremend sits between two blends this library already covers, and the interesting part is the ratio rather than the ingredients.

  1. 01
    It is Wolverine plus KPV
    BPC-157 and TB-500 are the two most-sold healing peptides. KPV is a three-amino-acid fragment of alpha-MSH marketed for inflammation. Add GHK-Cu and you have KLOW.
  2. 02
    The ratio is uneven, and that matters
    TB-500 sits at 25 mg against 10 mg each for the others. Every other blend in this family is close to 1:1, so a dose worked out from a Wolverine vial does not carry over.
  3. 03
    The evidence does not improve by stacking
    BPC-157 has no completed published randomized efficacy trial. TB-500 is a short fragment rather than the full thymosin beta-4 protein whose trials are usually quoted for it. KPV's work is mostly in animal models of colitis. Three thin evidence bases in one vial remain three thin evidence bases.
Where it acts
Whole body

Where this compound is thought to act.

03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Tissue and tendon repair, from the BPC-157 and TB-500 halvesResearch only
  • Gut inflammation, which is KPV's own claimResearch only
  • Recovery after injury, which is what the blend is marketed fornone

The published record

Research index

0

Papers and trials about Coremend blend (TB-500 / BPC-157 / KPV)

Europe PMC was searched on 12 October 2026 and returned nothing.

Counted from Europe PMC indexing, not read by a person.

Coremend blend (TB-500 / BPC-157 / KPV) vial rendering
Compound field notes

At a glance

Four things to know about Coremend blend (TB-500 / BPC-157 / KPV)

01

Evidence

Research only

02

Category

Healing and recovery

03

Common vial

Varies

04

Half-life

None of the three has a published human figure

04

How much, and do you cycle it?

The range, and whether you take breaks.

0.25 up to 0.5 mg BPC-157 per day (the rest follows your ratio), varies. Not established for the blend No range

No schedule has been studied for this combination. The components have different clearance times and different conventional frequencies, so a single shared schedule is a convenience of the vial rather than a finding.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

None of the three has a published human figureNo figure

BPC-157 has a rodent figure only. KPV has nothing published. The half-life quoted for TB-500 usually belongs to full-length thymosin beta-4, which is a different molecule. A blend has no single half-life. Each component clears on its own schedule, so one draw starts two or more different clocks. See each component's page.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

The published configuration is TB-500 25 mg, BPC-157 10 mg and KPV 10 mg in a 45 mg vial. Note the ratio is not 1:1: TB-500 is present at two and a half times the others, which is unusual in this family and changes what a single draw delivers. Coremend is one vendor's product name, so another seller's three-peptide healing vial may hold different amounts under a different name. Other sellers sell an even 10/10/10 vial of the same three peptides, often as Tri Blend.

Which vial do you have?

Pick your vial to see concentrations and a draw.

What you paid per vial
$
Used for cost per dose only.

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

Your draw

Pick which vial you have above. A blend holds 3 separate compounds, so the draw depends on how many milligrams of each are in your vial.

What one draw delivers

The same arithmetic as the calculator, worked out for the vials vendors sell.

Dose anchored to BPC-157, at the 0.25 to 0.5 mg per day people commonly cite. Each table assumes one draw per day. If you split it across more injections, divide the reading by the number of injections.

Vial
25 + 10 + 10 mg (45 mg total)
BPC-157 dose1 mL water2 mL water3 mL water
0.25 mg
2.5 units
  • TB-500 625 mcgbelow its usual 2 mg
  • BPC-157 250 mcg
  • KPV 250 mcg
5.0 units
  • TB-500 625 mcgbelow its usual 2 mg
  • BPC-157 250 mcg
  • KPV 250 mcg
7.5 units
  • TB-500 625 mcgbelow its usual 2 mg
  • BPC-157 250 mcg
  • KPV 250 mcg
0.5 mg
5.0 units
  • TB-500 1.25 mgbelow its usual 2 mg
  • BPC-157 500 mcg
  • KPV 500 mcg
10.0 units
  • TB-500 1.25 mgbelow its usual 2 mg
  • BPC-157 500 mcg
  • KPV 500 mcg
15.0 units
  • TB-500 1.25 mgbelow its usual 2 mg
  • BPC-157 500 mcg
  • KPV 500 mcg
Vial
10 + 10 + 10 mg (30 mg total)
BPC-157 dose1 mL water2 mL water3 mL water
0.25 mg
2.5 units
  • TB-500 250 mcgbelow its usual 2 mg
  • BPC-157 250 mcg
  • KPV 250 mcg
5.0 units
  • TB-500 250 mcgbelow its usual 2 mg
  • BPC-157 250 mcg
  • KPV 250 mcg
7.5 units
  • TB-500 250 mcgbelow its usual 2 mg
  • BPC-157 250 mcg
  • KPV 250 mcg
0.5 mg
5.0 units
  • TB-500 500 mcgbelow its usual 2 mg
  • BPC-157 500 mcg
  • KPV 500 mcg
10.0 units
  • TB-500 500 mcgbelow its usual 2 mg
  • BPC-157 500 mcg
  • KPV 500 mcg
15.0 units
  • TB-500 500 mcgbelow its usual 2 mg
  • BPC-157 500 mcg
  • KPV 500 mcg

No published human study establishes a dose for this blend. The range comes from vendor and community practice and is anchored to one component, because a blend is one draw.

On the 25/10/10 vial, a draw giving 500 mcg of BPC-157 gives 500 mcg of KPV and 1.25 mg of TB-500 alongside it. Daily dosing at that rate puts TB-500 near 8.75 mg per week, well above its own commonly cited 2 to 5 mg weekly range, and delivers it daily where it is usually given two or three times a week. The uneven ratio is the reason this blend behaves differently from the 1:1 Wolverine vial. On the even 10/10/10 vial the same draw gives 500 mcg each of TB-500 and KPV, which puts TB-500 near 3.5 mg per week, inside its commonly cited range.

What it costs

Coremend blend (TB-500 / BPC-157 / KPV) starts at $83.30 across 7 vendors, typically $2.78 – $10.00 per mg.

9 listings, last read Oct 10, 2026. Shipping and card fees are not included.

See all 9 listings →
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Coremend blend (TB-500 / BPC-157 / KPV) keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • Active cancer, as a precaution with anything that promotes tissue or blood-vessel growth
  • Anyone competing in drug-tested sport, because TB-500 is named on the WADA prohibited list
  • Anyone who wants established safety data, because none exists for this combination in humans

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction, including spreading hives, facial or throat swelling, or trouble breathing
  • Redness, heat, or pus at the injection site, which can signal infection
  • Any new lump or unexplained symptom

Common effects

Expected, and usually mild.
  • Redness, soreness, or a small bump at the injection site
  • Beyond that, unknown. No study has recorded what this combination commonly causes

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Coremend blend (TB-500 / BPC-157 / KPV) approved?

And where the numbers on this page come from.

No. Coremend blend (TB-500 / BPC-157 / KPV) is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    24 August 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Banned in drug-tested sport. Most research peptides are prohibited under WADA's S0 category, which covers any substance with no approval from any regulatory authority for human use. That means a compound can be banned without ever being named on the prohibited list. Check with your own anti-doping authority rather than assuming absence from the list means permitted.

You can compare this against the whole library, or read how to check a seller.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence